The endothelial nitric oxide synthase (Glu298Asp and-786T>C) gene polymorphisms are associated with coronary in-stent restenosis

被引:64
|
作者
Gomma, AH
Elrayess, MA
Knight, CJ
Hawe, E
Fox, KM
Humphries, SE
机构
[1] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6NP, England
[2] Natl Heart & Lung Inst, London, England
[3] London Chest Hosp, London E2 9JX, England
[4] Royal Free & & UCL Med Sch, Labs Cardiovasc Genet Studies, British Heart Fdn, London, England
关键词
eNOS polymorphism; restenosis; stents; genes; angiography;
D O I
10.1053/euhj.2002.3400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Coronary stent deployment is a major advance in percutaneous treatment of ischaemic heart disease, but 10-40% of patients still develop angiographic restenosis by 6 months due to neointimal hyperplasia. Patient-specific factors, including genetic factors, can contribute to this process. We have conducted a prospective study to examine the involvement of genetic risk factors (eNOS, ACE, MMP-3, IL-6, and PECAM-1) in restenosis following coronary stent deployment. showed a higher frequency of restenosis with an odds ratio of 1(.)88 (95%CI: 1(.)01-3(.)51, P=0(.)043) compared to 298Glu homozygotes. Carriers of the -786C allele of the eNOS -786T>C polymorphism also showed a higher frequency of restenosis with odds ratio of 2(.)06 (95%CI: 1(.)08-3(.)94, P=0(.)028). These effects were essentially additive and were independent of other classical risk factors. Other studied genes did not show significant association with coronary in-stent restenosis. Methods and Results A total of 226 patients who underwent elective and successful coronary artery stenting to de novo lesions in native coronary arteries were studied. Two hundred and five (90(.)7%) patients were restudied by coronary angiogram at 6 months and the stented lesions were assessed using an automated quantitative angiography system. Genotype was determined by polymerase chain reaction (PCR) and restriction enzyme digestion. Restenosis rate, defined as greater than or equal to50% diameter stenosis, was 29(.)3%. The overall genotype frequency distributions were in Hardy-Weinberg equilibrium for all variants. Carriers of the 298Asp allele of the eNOS Glu298Asp polymorphism Conclusion In patients with coronary artery disease, the possession of the 298Asp and -786C variants of the eNOS gene are a risk factor for coronary in-stent restenosis, demonstrating the importance of the nitric oxide system in restenosis. (C) 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1955 / 1962
页数:8
相关论文
共 50 条
  • [21] Endothelial Nitric Oxide Synthase Gene Polymorphisms (894G> T and-786T> C) and Risk of Coronary Artery Disease
    Alokail, Majed Saleh
    Alkharfy, Khalid M.
    Al-Daghri, Nasser M.
    Al-Attas, Omar S.
    Draz, Hossam M.
    Hussain, Tajamul S.
    Sabico, Shaun L.
    Bamakhramah, Ahmed A.
    FASEB JOURNAL, 2010, 24
  • [22] Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease
    Salimi, Saeedeh
    Firoozrai, Mohsen
    Zand, Hamid
    Nakhaee, Alireza
    Shafiee, Sayed M.
    Tavilani, Heidar
    Mohebbi, Ahmad
    ANNALS OF SAUDI MEDICINE, 2010, 30 (01) : 33 - 37
  • [23] Genetic risk factors for coronary artery spasm:: Significance of endothelial nitric oxide synthase gene T-786→C and missense Glu298Asp variants
    Yoshimura, M
    Yasue, H
    Nakayama, M
    Shimasaki, Y
    Ogawa, H
    Kugiyama, K
    Saito, Y
    Miyamoto, Y
    Ogawa, Y
    Kaneshige, T
    Hiramatsu, H
    Yoshioka, T
    Kamitani, S
    Teraoka, H
    Nakao, K
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 367 - 374
  • [24] Genetic risk factors for coronary artery spasm:: Significance of endothelial nitric oxide synthase gene T-786→C and missense Glu298Asp variants
    Yoshimura, M
    Yasue, H
    Nakayama, M
    Shimasaki, Y
    Mizuno, Y
    Harada, E
    Nakamura, S
    Ito, T
    Kuglyama, K
    Sakamoto, T
    Nakao, K
    CIRCULATION, 1999, 100 (18) : 819 - 819
  • [25] Endothelial nitric oxide synthase Glu298Asp gene polymorphism in periodontal diseases
    Berdeli, Afig
    Gurkan, Ali
    Emingil, Gulnur
    Atilla, Gul
    Kose, Timur
    JOURNAL OF PERIODONTOLOGY, 2006, 77 (08) : 1348 - 1354
  • [26] Functional gene testing of the Glu298Asp polymorphism of the endothelial nitric oxide synthase
    Veldman, B
    Rongen, G
    JOURNAL OF HYPERTENSION, 2001, 19 (07) : 1341 - 1341
  • [27] Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with Behcet's disease
    Oksel, F.
    Keser, G.
    Ozmen, M.
    Aksu, K.
    Kitapcioglu, G.
    Berdeli, A.
    Doganavsargil, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : S79 - S82
  • [28] The Glu298Asp mutation of the endothelial nitric oxide synthase gene in positively associated with essential hypertension
    Miyamoto, Y
    Saito, Y
    Kajiyama, N
    Yoshimura, M
    Shimazaki, Y
    Nakayama, M
    Kamitani, S
    Itoh, H
    Masuda, I
    Yoshimasa, T
    Nakagawa, O
    Yasue, H
    Nakao, K
    HYPERTENSION, 1997, 30 (03) : P64 - P64
  • [29] Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with advanced stage endometriosis
    Kim, Hoon
    Ku, Seung Yup
    Kim, Sung Hoon
    Lee, Gyoung Hoon
    Choi, Young Min
    Kim, Jong Mee
    Lee, Taek Hoo
    Moon, Shin Yong
    HUMAN REPRODUCTION, 2009, 24 (10) : 2656 - 2659
  • [30] The Glu298Asp and T-786C variants of the endothelial nitric oxide synthase (eNOS) gene and risk of coronary heart disease (CHD) in US men.
    Pai, JK
    Hunter, D
    Kraft, P
    Rimm, E
    CIRCULATION, 2004, 109 (07) : E86 - E86